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Research
Bisphenol A (BPA) has received heightened 
attention in the last decade because of its 
ubiquitous presence. BPA is used in the pro-
duction of polycarbonate plastics and epoxy 
resins, including the resins used to coat the 
inside of food and beverage cans, and for den-
tal composites and sealants (Olea et al. 1996; 
Vandenberg et al. 2007; Ye et al. 2009). A 
growing body of evidence supports the chronic 
nature of human BPA exposure. BPA was 
detected in the urine of > 92% of Americans 
tested, with higher levels present in children 
and adolescents relative to adults (Calafat 
et al. 2008). BPA has also been detected in 
maternal (Padmanabhan et al. 2008) and fetal 
plasma, placenta, and amniotic fluid (Ikezuki 
et al. 2002; Schönfelder et al. 2002) and in 
breast milk (Sun et al. 2004). The levels of 
urinary BPA in pre  mature infants in neonatal 
intensive care units are approximately 10 times 
higher than those in the general population 
(Calafat et al. 2009). 
BPA has been considered to be a weak 
estrogen because of its low potency compared 
with estradiol in assays involving nuclear 
receptors (Blair et al. 2001; Thomas and Dong 
2006). However, low levels of BPA can act 
additively with other xeno  estrogens as well as 
with natural estrogens (Silva et al. 2002; Soto 
et al. 1994, 1997; Tollefsen 2002). BPA can 
also act via membrane receptors to produce 
effects that are similar in potency to those 
of estradiol (Welshons et al. 2006; Wozniak 
et al. 2005). These findings stress the relevance 
of low-dose exposures, particularly during the 
perinatal period, when BPA may affect the 
development of estrogen target organs.
Developmental exposure to endocrine dis-
ruptors has been postulated to play a role in 
the increased incidence of malformations of 
the male genital tract and testicular and breast 
cancers observed in the European and U.S. 
populations during the last half century, a 
time when numerous hormonally active chem-
icals were introduced into the environment 
(Diamanti-Kandarakis et al. 2009; Jouannet 
et al. 2001; Skakkebaek 1998; Skakkebaek 
et al. 2001). Epidemiological studies of 
women born in Denmark have suggested 
that young cohorts had progressively lower 
total fertility rates that were compensated for 
by the increased use of assisted reproductive 
technologies (Jensen et al. 2008). In a labora-
tory setting, female mice exposed in utero to 
environmentally rele  vant doses of BPA have 
shown advanced puberty (Howdeshell et al. 
1999), alterations in estrous cyclicity, and an 
increase in the percentage of ovarian antral 
follicles (Markey et al. 2003). Early BPA 
exposure resulted in increased proliferative 
activity of epithelial cells in the endometrial 
glands and increased expression of estrogen 
receptor-α (ERα) and progesterone receptor 
in the luminal epithelium of the endometrium 
and in the sub  epithelial stroma of exposed 
mice (Markey et al. 2005). Perinatal exposure 
of mice to BPA also decreased sex differences 
in the antero  ventral peri  ventricular nucleus 
of the hypothalamus (Rubin et al. 2006), a 
nucleus known to be important for the preo-
vulatory luteinizing hormone (LH) surge. In 
addition, BPA exposure during gestation and 
lactation accelerated the onset of acyclicity in 
rats (Rubin et al. 2001). Taken together, these 
multiple effects of BPA exposure during early 
development might be expected to compro-
mise overall reproductive success.
The above-mentioned effects observed 
after early exposure to BPA are reminiscent 
of those observed after fetal exposure to 
another estrogenic compound, diethylstil-
bestrol (DES), which was widely prescribed 
to prevent miscarriages in pregnant women 
(Newbold 2008). Fetal exposure to DES 
resulted in oviduct malformations in mice 
during adulthood (Newbold et al. 1983) and 
uterine fibroids in women later in life (Baird 
and Newbold 2005; McLachlan et al. 1980). 
Early exposure to DES also advanced the age 
of vaginal opening and the age at first estrous 
in mice (Honma et al. 2002). In addition, 
prenatal exposure to DES altered the repro-
ductive capacity of female mice in a forced 
breeding protocol (McLachlan et al. 1982). 
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Ba c k g r o u n d: Perinatal exposure to low-doses of bisphenol A (BPA) results in alterations in the 
ovary, uterus, and mammary glands and in a sexually dimorphic region of the brain known to be 
important for estrous cyclicity.
oBjectives: We aimed to determine whether perinatal exposure to environmentally relevant doses 
of BPA alters reproductive capacity.
Me t h o d s : Female CD-1 mice that were exposed to BPA at 0, 25 ng, 250 ng, or 25 μg/kg body 
weight (BW)/day or diethylstilbestrol (DES) at 10 ng/kg BW/day (positive control) from gestational 
day 8 through day 16 of lactation were continuously housed with proven breeder males for 32 weeks 
starting at 2 months of age. At each delivery, pups born to these mating pairs were removed. The 
cumulative number of pups, number of deliveries, and litter size were recorded. The purity of the 
BPA used in this and our previous studies was assessed using HPLC, mass spectrometry, and nuclear 
magnetic resonance.
re s u l t s: The forced breeding experiment revealed a decrease in the cumulative number of pups, 
observed as a non  monotonic dose–response effect, and a decline in fertility and fecundity over time 
in female mice exposed perinatally to BPA. The BPA was 97% pure, with no evidence of contami-
nation by other phenolic compounds.
co n c l u s i o n s: Perinatal exposure to BPA leads to a dose-dependent decline in the reproductive 
capacity of female mice. The effects on the cumulative number of pups are comparable to those 
previously reported in mice developmentally exposed to DES, a compound well known to impair 
reproduction in women. This association suggests the possibility that early BPA exposure may also 
affect reproductive capacity in women.
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This protocol revealed significant effects of 
DES, even at low doses, in stark contrast with 
the lack of effect of DES reported in stud-
ies that examined only the first pregnancy in 
DES-exposed females (Honma et al. 2002).
Based on the wide variety of effects on the 
reproductive system caused by fetal and/or   
neonatal exposure to BPA, and the repro-
ductive effects caused by early exposure to 
DES, we hypothesized that perinatal exposure 
to BPA impairs the reproductive function 
of exposed females (Maffini et al. 2006). In 
the present study, we tested this hypothesis 
by assessing fertility and fecundity in BPA-
exposed CD-1 mice over a period of 32 weeks 
in a forced breeding regimen.
Materials and Methods
Chemicals. Dimethyl sulfoxide (DMSO; 
CAS no. 67-68-5), DES (CAS no. 56-53-1), 
and BPA (4,4´-dihydroxy  diphenyl dimethyl-
methane; CAS no. 80-05-7; product no. 
23965-8, lot no. 03105ES; purity ≥ 99%) were 
purchased from Sigma Chemical Company 
(Saint Louis, MO, USA). We further analyzed 
the purity of the BPA stock by HPLC using 
a Spectra P1000 pump (Thermo Separation 
Products, Les Ulis, France) associated with a 
250 mm × 4.6 mm (5 μm) Zorbax SB-C18 
column protected by a Kromasil C18 guard 
precolumn (Agilent; Interchim, Montluçon, 
France). Mobile phases and analytical condi-
tions were as previously described (Jaeg et al. 
2004). The system was coupled to a diode area 
detector (UV6000LP Spectra System; wave-
length range, 220–360 nm; Thermo Separation 
Products). Next, the mass spectrometric (MS) 
analysis of BPA was performed on a quadruple 
ion trap LCQ mass spectrometer (Thermo 
Electron, Les Ulis, France) equipped with an 
electrospray ionization (ESI) source. Finally, 
the nuclear magnetic resonance (NMR) 
spectrum of BPA was obtained at 300K on 
a Bruker Avance DRX-600 spectrometer 
(Bruker, Wissembourg, France) operating at 
600.13 MHz and equipped with a 5-mm H, 
C, N inverse triple-resonance TXI cryo  probe 
attached to a cryo  platform (the pre  amplifier 
cooling unit). BPA (1 mg) was dissolved in 
600 μL deuterated methanol (CD3OD), 
and one-dimensional spectrum was acquired 
using a standard pulse sequence for 1H NMR. 
Sixteen free induction decays were collected 
with a spectral width of 12 ppm into 64,000 
data points. 
Animals. CD-1 female mice (12 weeks of 
age) and proven breeder male mice (all from 
Charles River Laboratories, Wilmington, MA, 
USA) were maintained in temperature- and 
light-controlled (14/10-hr light/dark cycle) 
conditions at the at Tufts University Human 
Nutrition and Research Center animal facility 
(approved by the Association for Assessment 
and Accreditation of Laboratory Animal Care 
International). All experimental procedures 
were approved by the Tufts University–New 
England Medical Center Institutional Animal 
Care and Use Committee. The animals were 
treated humanely and with regard for allevia-
tion of suffering. Cages, water, and bedding 
all tested negligible for estrogenicity by the 
E-SCREEN assay (Soto et al. 1992). Water 
was supplied ad libitum from glass bottles. 
Food (Teklad 2018; Harlan, Indianapolis, IN, 
USA) was supplied ad libitum. The estroge-
nicity of food lots used was measured by the 
E-SCREEN assay and found to be negligible 
(< 20 pmol estrogen equivalents per gram of 
feed). The estrogenic activity of the feed was 
also tested independently by W.V. Welshons 
in his laboratory (Welshons et al. 1990).
Mice were allowed to acclimatize for 
5 days before being paired to mate. The 
morning on which a vaginal plug was detected 
was considered gestational day (GD) 1. On 
the evening of GD8, dams were implanted 
subcutaneously with Alzet osmotic pumps 
(model 1004; Alza Corp., Palo Alto, CA, 
USA) following the manufacturer recom-
mendations. Pumps were designed to deliver 
vehicle alone (50% DMSO in water), the 
positive control (DES), or one of three doses 
of BPA. These pumps continued to release at 
a constant rate (0.11 μL/hr) until day 16 of 
lactation. The actual delivered dose of BPA 
decreased as pregnancy progressed because 
the weight of the mother at GD6 was used to 
calculate BPA dose, and body weights (BW) 
increased from this point throughout preg-
nancy. BPA exposure groups were 0 (control), 
25 ng, 250 ng, and 25 μg BPA/kg BW/day. 
DES was administered at 10 ng/kg BW/day, 
which was the lowest effective dose tested in 
a forced breeding regimen (McLachlan et al. 
1982). The dams delivered naturally, and the 
F1 litters were culled to eight pups on the day 
after birth, keeping at least two males. Litters 
were weaned on postnatal day 21.
Experimental design. At 8 weeks of age, 
one F1 female mouse from each treatment 
group was randomly chosen from each litter 
and individually housed with a non  exposed 
young male of proven fertility for a period 
of 32 weeks. A total of 18–21 dams in each 
Figure 1. Diode area detector HPLC-UV analysis (A) and 600 MHz 1H NMR spectrum (B) of the BPA used in these experiments (Sigma Aldrich catalog no. 23965-8).
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group delivered litters (control, n = 21; BPA 
25 ng/kg, n = 19; BPA 250 ng/kg, n = 18; 
BPA 25 μg/kg, n = 20; DES, n = 20). All the 
breeding cages were examined daily. On the 
day of each delivery, F2 pups were separated 
from the mother, and their number, sex, and 
weight were recorded. The pups were sacri-
ficed by decapitation, and the F1 dam was 
immediately returned to the breeding cage. 
The cumulative number of live pups deliv-
ered, time to first litter, number of deliveries 
(fertility) per dam, number of neonates per 
litter (fecundity), and number of mice having 
litters were recorded.
Statistics. We used SPSS statistical soft-
ware (version 15.0; SPSS Inc., Chicago, 
IL, USA) for all statistical analyses. The 
Kolmogorov-Smirnov test was used to assess 
differences in the cumulative number of pups 
between treatment groups. Differences in the 
total number of pregnancies were assessed 
using analysis of variance (ANOVA) and 
Dunnett’s post hoc test. Fisher’s exact test was 
used to analyze differences in the proportions 
of female mice in each treatment group with 
four or more pregnancies. All these results are 
presented as mean ± SE or percentages. To 
study fecundity, scatter plots and trend lines 
of the number of pups versus delivery number 
were produced for each treatment group. The 
slope and correlation coefficient (R) of the 
trend lines were each compared across treat-
ment groups using t-tests. For all statistical 
tests, results were considered significant at 
p < 0.05.
Results
Purity of BPA. When analyzed by HPLC 
with ultra  violet (UV) detection, the reten-
tion time of our BPA stock (43 min) was 
identical to that expected for authentic BPA 
(Zalko et al. 2003). Based on UV absorbance 
at 269 nm, BPA purity was close to 100% 
(Figure 1A). We detected minor impuri-
ties at lower wavelengths that eluted from 
the column with retention times of 10 min 
(major peak) and 22–23 min (minor peak), 
respectively. ESI-MS analysis detected the 
molecular ion of BPA (negatively charged) 
at m/z 227, consistent with its molecular 
mass of 228.We observed no other ion in 
the mass spectrum, indicating that inter-
fering compounds were not present or were 
undetectable. The MS/MS analysis confirmed 
the structure of BPA, with a fragment ion 
detected at m/z 212, corresponding to the loss 
of one methyl group, as well as a fragment 
ion at m/z 133, diagnostic of the elimina-
tion of the phenol moiety. The NMR analysis 
showed two doublets at 7.01 and 6.65 ppm 
and the singlet at 1.57 ppm, characteristic of 
BPA. The singlet at 1.28 ppm did not belong 
to BPA; we concluded that it was associated 
with the presence of an impurity, which we 
estimated by integration measurements to 
account for 3 ± 2% of the sample. In addi-
tion, in the 1H NMR spectrum, the signals 
between 0.8 and 2.5 ppm corresponding to an 
impurity (Figure 1B) strongly suggested that 
this impurity was not a phenolic compound. 
The degree of purity determined for the BPA 
used for these experi  ments (97 ± 2%) was 
comparable to that reported by the manufac-
turer (≥ 99%).
Growth and reproduction parameters. We 
observed no statistical differences in the dam 
weights by treatment groups. The percentage 
of dead pups and the sex ratio were compa-
rable in all groups (Table 1). Additionally, 
when mated at 2 months of age, the time 
to first delivery did not differ by treatment 
group (Table 1).
Cumulative number of pups per dam. 
The cumulative number of live pups born 
to BPA 25 ng/kg mice was significantly 
lower compared with controls starting at 
week 16 (mean ± SE, 49.74 ± 4.21 pups 
vs. 67.48 ± 4.38 pups; p = 0.037) and 
persisted until the end of the experi  ment 
(67.00 ± 5.70 pups vs. 81.90 ± 5.45 pups; 
p < 0.001) (Figure 2). BPA 25 μg/kg mice 
also had significantly lower cumulative num-
ber of pups per dam compared with control 
mice. We observed a statistically significant 
difference between this group and controls 
beginning at week 16 (49.85 ± 3.69 pups 
vs. 67.48 ± 4.38 pups; p = 0.037) that per-
sisted until the end of the experiment 
(58.25 ± 4.77 pups vs. 81.90 ± 5.45 pups; 
p < 0.001). The cumulative number of pups 
born to mice exposed to DES was also sig-
nificantly lower than in the controls, begin-
ning at week 25 (64.55 ± 6.44 pups 
vs. 80.00 ± 5.19 pups) and persisting 
until week 32 (65.70 ± 6.66 pups vs. 
81.90 ± 5.45 pups; p < 0.01). The cumula-
tive numbers of pups did not differ between 
the control and BPA 250 ng/kg groups at any 
time point. However, the BPA 250 ng/kg   
group differed from the BPA 25 ng/kg and 
BPA 25 μg/kg groups [77.89 ± 6.64 pups 
vs. 57.00 ± 4.89 pups (p = 0.042) and 
Table 1. Outcomes of forced reproduction experiment. 
Treatment
No. of 
dams
Total no. of pups Percent 
dead pups
Pup sex 
ratioa
Time to first 
delivery (days)
Dam weight at  
sacrifice (g) Dead Live
Control 20 29 1,720 1.66 0.554 21.90 ± 2.61 71.24 ± 3.54
BPA
25 ng 19 16 1,273 1.24 0.463 22.68 ± 3.87 67.59 ± 2.38
250 ng 18 10 1,588 0.63 0.530 21.22 ± 1.35 72.95 ± 3.05
25 µg 20 26 1,165 2.18 0.506 21.05 ± 1.19 72.93 ± 2.48b
DES 20 11 1,501 0.73 0.488 21.73 ± 1.78 78.35 ± 2.51c
Values for time to first delivery and dam weight at sacrifice are given as mean ± SE.
aRatio of males to females. bTwo dams died at 8 months of age, before the end of the study; the cause of the deaths 
could not be established. cThree dams died (two dams at 3 months and one dam at 8 months of age) before the end of 
the study; the cause of the deaths could not be established. 
Figure 2. Reproductive capacity of mice exposed perinatally to BPA or 10 ng/kg BW/day DES, expressed 
as the cumulative number of pups born per dam over a period of 32 weeks of forced breeding (mean ± SE). 
n, number of dams at the beginning of each experiment. Statistical analysis was performed using the 
Kolmogorov–Smirnov test. 
For BPA 25 ng/kg and BPA 25 µg/kg compared with controls during the same week, *p < 0.05 for weeks 16–24, and 
**p < 0.01 for weeks 25–32. For DES compared with controls for the same week, #p < 0.05 for weeks 25–32. 
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56.20 ± 4.19 pups (p = 0.042), respectively] 
starting at week 21 and persisting until the 
end of the study period [88.22 ± 7.95 pups 
vs. 67.00 ± 7.70 pups (p < 0.001) and 
58.25 ± 4.77 pups (p < 0.001), respectively]. 
Likewise, we observed a statistically sig-
nificant difference between BPA 250 ng/kg   
and DES groups beginning at week 27 
(86.11 ± 7.39 pups vs. 65.45 ± 6.62 pups; 
p = 0.037) and persisting until the end 
(88.22 ± 7.95 pups vs. 65.70 ± 6.66 pups; 
p < 0.004).
Fertility. We assessed fertility by the total 
number of litters per dam for each treatment 
group at the end of the 32-week period of 
forced breeding. Dams in the BPA 25 μg/kg 
group had significantly fewer pregnancies than 
the control dams (p = 0.024) (Figure 3A). We 
observed a trend toward a decreased number 
of pregnancies in the BPA 25 ng/kg group 
(5.74 ± 0.48 pregnancies) and DES group 
(5.5 ± 0.44 pregnancies) relative to controls 
(6.37 ± 0.39 pregnancies). The proportion of 
dams with six or more litters was significantly 
lower in the BPA 25 μg/kg group (35%) than 
in the controls (76%) (Figure 3B), as was the 
proportion of mice with four or more litters 
in the BPA 25 μg/kg group (60%) compared 
with the controls (95%; p = 0.012).
Fecundity. We created scatterplots to 
depict the number of pups born at each deliv-
ery for each treatment group, determined a 
best-fit line for each treatment group, and 
compared the slopes and correlation coeffi-
cients (R) of these lines (Figure 4). The differ-
ence in correlation coefficients indicated that 
the variation in fecundity within each treat-
ment group that is attributed to aging dif-
fered for the BPA 25 μg/kg group (R = 0.60) 
compared to the control (R = 0.36; p = 0.025) 
and BPA 250 ng/kg (R = 0.30; p = 0.005) 
groups. The differences in slope indicated that 
the decline in number of pups delivered over 
time was hastened in the BPA 25 μg/kg group 
compared with the control (p = 0.012) and 
BPA 250 ng/kg (p = 0.003) groups.
Discussion
Developmental plasticity has been a cen-
tral theme in embryology (Gilbert and Epel 
2009), and it is currently being explored in 
medicine and public health because of growing 
evidence from studies in animal models and 
humans that various adult-onset diseases, such 
as obesity, diabetes, and cancer, may have their 
origins during fetal life (Bateson et al. 2004; 
Newbold et al. 2008; Soto and Sonnenschein 
2010). Exposure to environmental endocrine 
disruptors during fetal development has been 
postulated to contribute to declining concep-
tion rates and increased incidence of female 
reproductive disorders such as oocyte aneu-
ploidy, poly  cystic ovarian syndrome, and 
altered cyclicity, as well as endometriosis, 
uterine fibroids, fetal growth retardation, and 
pregnancy loss (Crain et al. 2008). Perinatal 
exposure to environmentally relevant doses of 
BPA has resulted in early vaginal opening and 
altered estrous cyclicity, over  expression of ERα 
and progesterone receptor in the endometrium, 
and an increased number of ovarian antral fol-
licles in mice (Markey et al. 2003, 2005). All 
of these studies suggest the likelihood of func-
tional consequences such as altered reproduc-
tive outcomes in BPA-exposed females.
In the present study, perinatal exposure 
to BPA resulted in a decline in reproductive 
capacity in a forced-breeding protocol. BPA 
25 μg/kg mice showed a significant decrease 
in the number of pregnancies, indicating a 
decline in fertility. We also observed a signif-
icant decrease in the cumulative number of 
pups born to BPA 25 ng/kg, BPA 25 μg/kg, 
and DES dams relative to controls. The BPA 
25 μg/kg group showed a progressive decline 
in the number of pups delivered, which sug-
gests the possibility of an accelerated repro-
ductive decline. These effects are consistent 
with previously reported alterations in the 
ovary, uterus, hypothalamus, and pituitary, 
the estrogen target tissues that are essential for 
successful delivery of live pups. Therefore, all 
these BPA-associated alterations undoubtedly 
contribute to the diminished reproductive out-
come observed here. The forced breeding pro-
tocol does not allow for detailed evaluation 
of fertilization, implantation, and pregnancy 
maintenance, including the potential for early 
pregnancy loss in these animals. The protocol 
records successful pregnancies and provides 
information about litter size and composition. 
Therefore, it is impossible to pinpoint a single 
cause of the reduced fertility observed with 
peri  natal BPA exposure. The overall pattern 
observed is suggestive of accelerated reproduc-
tive decline, which could have involved changes 
in the function of any or several of the poten-
tial BPA target tissues, including alterations 
at the hypothalamus/pituitary level linked to 
aging that could have interfered with the preo-
vulatory LH surge and the number of ova ovu-
lated. This study stresses the need to identify 
the primary targets and the precise sequence of 
events leading to compromised reproduction.
In contrast to the significant effects on 
reproductive capacity revealed over time by 
this forced breeding experiment, neither the 
time to first delivery nor the number of pups 
in the first litter was affected by BPA expo-
sure. Standard toxicological studies on BPA 
and other endocrine disruptors have routinely 
analyzed the effects on first pregnancy alone, 
with no follow-up on potential effects in sub-
sequent pregnancies. As a result, they failed 
to identify changes in reproductive functions 
that manifest during subsequent pregnancies, 
leading to an incomplete evaluation of the 
effects of BPA exposure on fertility. This was 
pointed out by Honma et al. (2002), who 
acknowledged that although DES did not 
affect reproduction in their experiments, it did 
affect reproductive parameters in prior forced 
breeding assays. The forced breeding proto-
col we used in the present study was adapted 
from McLachlan et al. (1982), who noted a 
dose-related decrease in reproductive capac-
ity ranging from a decline of the cumulative 
number of pups in mice exposed prenatally to 
10 ng DES/kg BW/day to a high frequency 
Figure 3. Results after 32 weeks of forced breeding expressed as (A) the total number of litters per dam (mean ± SE) and (B) percentage of CD-1 female mice per 
group with greater than or fewer than six litters. n, number of dams at the beginning of each experiment. 
#p = 0.024 compared with control, by ANOVA followed by Dunnett’s test. ##p = 0.012 compared with control, by Fisher’s exact test. 
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of sterility at the highest dose of 100 μg DES/
kg BW/day compared with non  exposed con-
trols. In our study, exposure to 10 ng DES/
kg BW/day resulted in a significant decline in 
the cumulative number of pups born to the 
treated mice relative to controls.
Of interest, the intermediate BPA dose, 
250 ng/kg, did not produce significant effects 
in the forced breeding regimen, whereas 
both lower and higher doses did. Natural 
hormones often show non  monotonic dose–
response curves (Amara and Dannies 1983; 
Sonnenschein et al. 1989; Vandenberg et al. 
2006; Wadia et al. 2007), which have also 
been reported for several endocrine disrup-
tors (Myers and Hessler 2007). These curves 
are believed to represent a composite of 
effects over diverse targets (Vandenberg et al. 
2006). Non  monotonic dose–response curves 
induced by BPA have been documented in 
human prostate cancer cell line proliferation 
(Wetherill et al. 2002), rat pituitary and cer-
ebellar cortex cells (Wozniak et al. 2005), 
and production of adipo  nectin by human 
adipocytes (Hugo et al. 2008). Our data 
now add reproductive capacity to the list 
of non  monotonic responses to BPA expo-
sure. However, it is important to note that 
although the reproductive capacity of the 
BPA 250 ng/kg females did not appear to be 
affected in our forced breeding regimen, it 
is possible that other experimental protocols 
would reveal evidence of impaired reproduc-
tive function in this treatment group. Indeed, 
we have observed alterations in estrous cyclic-
ity and antral follicle number (Markey et al. 
2003), mammary gland development (Munoz 
de Toro et al. 2005), and the hypothalamus of 
females exposed to 250 ng BPA/kg BW/day   
(Rubin et al. 2006). The forced breeding 
protocol used here eliminates regular estrous 
cycles and spontaneous preovulatory LH 
surges during the 32 weeks of breeding; there-
fore, it might mask relevant reproductive defi-
cits in this treatment group.
In an earlier study, CD-1 mice exposed to 
a single bolus injection of a low dose of BPA 
(25 μg/kg BW) showed significant levels of 
BPA residues (4% of the dose) in fetuses, con-
firming the passage of BPA through the pla-
cental barrier (Zalko et al. 2003). The finding 
with regard to the purity of the BPA used in 
the present study and all our previous studies 
strongly indicates that it is BPA and not a con-
taminant that is responsible for the observed 
effects in exposed offspring. To date, most 
reports on BPA toxicity rely on the manufac-
turer’s claim of the purity of the chemical. In 
the present study we independently assessed 
and confirmed the purity of the commercial 
BPA used. In addition, the analysis indicated 
that the potential for any impurity to corre-
spond to another phenolic compound is neg-
ligible. This finding strongly suggests that the 
effects observed are due to BPA.
Numerous responses to BPA cited above 
and responses observed in the present study 
occur with BPA levels that are below the cur-
rent U.S. Environmental Protection Agency 
reference dose for this chemical (50 μg/kg 
BW/day) (Welshons et al. 2003; IRIS-USEPA 
2002). In fact, in the present study we used 
doses that were 2- and 2,000-fold below the 
current safe dose of BPA. Some of the effects 
observed at low doses are not found at much 
higher doses (Myers et al. 2009). Therefore, 
the current practice in regulatory toxicology of 
testing chemicals at very high doses might not 
reliably predict the hazards posed by low doses 
of endocrine-disrupting chemicals such as BPA.
The current rise in the incidence of infer-
tility cases as well as the advanced onset of 
puberty in girls may be significantly influenced 
by the exposure to multiple hormonally active 
chemicals in our environment. Our findings 
of reproductive effects in mice after peri  natal 
exposure to low doses of BPA suggest the pos-
sibility that environ  mental exposures to low 
BPA doses might affect human reproductive 
health as well and support the need to strictly 
regulate its use.
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